Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Ian M. Leitch (ORCID: https://orcid.org/0000-0002-2465-3036)
- Arshad M. Khanani (ORCID: https://orcid.org/0000-0001-8928-5599)
- Charles C. Wykoff (ORCID: https://orcid.org/0000-0001-7756-5091)
- Jason S. Slakter
- Timothy L. Jackson (ORCID: https://orcid.org/0000-0001-7618-1555)
- Chui Ming Gemmy Cheung (ORCID: https://orcid.org/0000-0003-3358-3516)
- Megan E. Baldwin
Institutions
- University of Nevada, Reno (US)
- King's College London (GB)
- Cornell University (US)
- Singapore National Eye Center (SG)
- NYU Langone Health (US)
- Methodist Hospital (US)
- Retina Consultants of Texas (US)
- Sierra Eye Associates (US)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1016/j.xops.2025.100759
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00